Christina Smolke is the co-founder and CEO of Antheia. Antheia is a synthetic biology company -- they’re in the business of genetically engineering microorganisms to produce commercial products.
Christina’s problem is this: How do you turn yeast cells into tiny factories to create the active ingredients in generic drugs. If Christina and her team solve this problem, they won’t solve the drug shortage problem entirely. But they might help make it better.
See omnystudio.com/listener for privacy information.
Making Palm Oil Without Palm Trees
Fighting Cancer with CRISPR
How to Start 40 Companies (and Counting)
The Cutting Edge of Energy Storage: Rust
The First Pig to Human Kidney Transplant
Designing a Drone That Delivers
How Do Psychedelics Work?
Building Boundary-Breaking Balloons
Building a Robot That Can Walk the Walk
Building From the Ground Up: NNG Capital Fund
Can Your Phone Tell When You're Getting Sick?
The High-Stakes Quest to Reinvent Cement
How a Battery-Powered Stove Could Electrify America
3D Printing a Better Rocket
Using AI to Help Doctors Save Lives
Making Dam Good Hydropower
Using AI to Build Better Robots
Teaching Computers to See
Using Oil-Industry Tech to Create Clean Energy
Understanding Obesity and Alzheimer’s via Epigenomics
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
Radiolab
NABOR® TALKS
U.S Property Podcast
Aligned Money Show
The Ramsey Show